The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.
Inclusion Criteria:
Exclusion Criteria:
Phoenix, Arizona, United States
Gold River, California, United States
Laguna Hills, California, United States
Los Gatos, California, United States
Murrieta, California, United States
Riverside, California, United States
Denver, Colorado, United States
Hialeah, Florida, United States
Jacksonville, Florida, United States
Merritt Island, Florida, United States
Miami, Florida, United States
Naples, Florida, United States
North Miami Beach, Florida, United States
Orlando, Florida, United States
Pinellas Park, Florida, United States
Sarasota, Florida, United States
St. Petersburg, Florida, United States
Sunrise, Florida, United States
Winter Park, Florida, United States
Marietta, Georgia, United States
Newnan, Georgia, United States
Bloomington, Illinois, United States
Carmel, Indiana, United States
Shreveport, Louisiana, United States
City of Saint Peters, Missouri, United States
Hartsdale, New York, United States
Eugene, Oregon, United States
State College, Pennsylvania, United States
Charleston, South Carolina, United States
Dallas, Texas, United States
Sandy City, Utah, United States
Edmonds, Washington, United States